Influenza Diagnostics Market – Screening Product Awareness 2025
The global market for influenza diagnostics is slated to expand at a promising pace in the next few years as the incidences of influence are rising at a massive pace on the globe front. A common illness of the respiratory system, the condition is responsible for between 250,000 to 500,000 deaths across the globe every year. As the virulent spread of the condition creates increased concerns across the world, government bodies, medical organizations, and pharmaceutical companies are all focusing on the introduction of effective measures for the diagnosis and treatment of the condition.
Request Sample Copy of the Report @
In the next few years, the market will be driven by the increased efforts of governments across emerging economies put more focus on the development of healthcare infrastructures in general, increased awareness among the global population about available diagnostic methods, and rising expenditure on healthcare. The intense level of competition in the healthcare and pharmaceutical industries is also compelling companies to become more aggressive in the areas of research and development and the introduction of more effective, innovative interventions to attract new consumers. This trend could also prove to be important for the overall development of the global influenza diagnostics market.
Global Influenza Diagnostics Market: Overview
As the frequency of outbreaks of influenza increases globally, the global market for influenza diagnostics is likely to soar. Commonly known as flu, influenza is an illness of the respiratory system caused by viruses. According to the World Health Organization (WHO), influenza is responsible for 250,000 to 500,000 deaths worldwide, making it the second leading disease resulting in mortality, after acquired immune deficiency syndrome (AIDS).
Types of influenza include pandemic, avian, seasonal, and swine (variant) flu. Numerous tests aid in the diagnosis and treatment of influenza. Some of these available diagnostic tests are serology, viral culture, rapid molecular assays, reverse transcription polymerase chain reaction (RT-PCR), and immunofluorescence assays.
Request TOC of the Report @
Global Influenza Diagnostics Market: Key Trends
The increasing incidence of various forms of influenza across the globe, growing investments in research and development, rising pediatric focus, and encouraging policies of the government are driving the global market for influenza diagnostics. As faster and more accurate diagnostic tests are increasingly sought after, a number of market players have undertaken the development of more efficient tests that give quicker results.
Conversely, stringent regulatory frameworks, delays in the approval process of new tests, and limited infrastructure (in developing nations in particular), might emerge as the key deterrents of the global market for influenza diagnostics. Nevertheless, technological advancement in the domain of influenza diagnostics can offer extensive opportunities for growth.
Global Influenza Diagnostics Market: Market Potential
As the virulent spread of influenza across numerous regions of the world has created concern across countries. Considering the spread of influenza governments, pharmaceutical companies, and medical organizations are striving to introduce effective diagnostics and medications. As of March 2017, 16 from North Carolina, 3 in Delaware, 7 in San Diego died of influenza. Almost 4,000 residents of Arizona suffered from influenza during February 2017. Likewise, in Malaysian state Perak around 273 school children were found to suffer from influenza-like illness during the same month.
Consequently, in March 2017, GlaxoSmithKline plc, a leading market player, announced its submission of an application to the FDA for obtaining approval to expand its label of an influenza vaccine, Fluarix Quadrivalent, for children aged six months and older. Presently, the vaccine is administered to patients aged three and above. It is an active immunization against type A and type B influenza viruses.
The fifth wave of H7N9 in China resulted in 1,223 cases, with 380 fatalities, according to the WHO. Consequently, growing concerns pertaining to the avian influenza led to the announcement of the development of two novel pandemic vaccines by Protein Sciences Corporation. The announcement was made following a request for the same by the Biomedical Advanced Research and Development Authority (BARDA), a division of the U.S. Department of Health and Human Services. The company boasts owning the single FDA approved technology for fast production of influenza vaccines.
Global Influenza Diagnostics Market: Regional Outlook
Based on geography, the global market for influenza diagnostics can be segmented into Latin America, the Middle East and Africa, North America, Asia Pacific, and Europe. As countries such as Australia, the U.S., Greece, China, Spain, India, and Malaysia have been witnessing outbreaks of influenza, the demand from these regions will mount up to a great degree.
Read Comprehensive Overview of Report @
The influenza diagnostics market in Asia Pacific is slated for significant growth over the forecast period, propelled by the increasing healthcare spending, favorable government initiatives, greater demand for cutting-edge diagnostics technologies, and expanding disposable incomes of the middle class populace in the region.
Global Influenza Diagnostics Market: Competitive Analysis
Some of the major companies operating in the global market for influenza diagnostics are Becton, Dickinson and Company, Luminex Corporation, Thermo Fisher Scientific, Alere Inc., GlaxoSmithKline plc, DiaSorin, Roche Diagnostics, SA Scientific, and Quidel Corporation.
Product development is a key business strategy of market players. For instance, Becton, Dickinson and Company recently announced FDA approval for its new digital immunoassay, BD Veritor™ System Flu A+B, which is able to rapidly detect influenza.
About TMR Research
TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends. Our savvy custom-built reports span a gamut of industries such as pharmaceuticals, chemicals and metals, food and beverages, and technology and media, among others. With actionable insights uncovered through in-depth research of the market, we try to bring about game-changing success for our clients.
3739 Balboa St # 1097,
San Francisco, CA 94121
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Influenza Diagnostics Market – Screening Product Awareness 2025 here
News-ID: 1232547 • Views: 300
More Releases from TMR Research
Cosmetic and Perfume Glass Packaging Market - Survey On Potential Players 2030 | …
Cosmetic and Perfume Glass Packaging Market: Overview The demand within the global cosmetic and perfume glass packaging market is slated to escalate in the times to follow. There is little contention about the importance of developing skin-friendly perfumes and cosmetics, prompting the manufacturers to ramp up their quality standards. However, quality of cosmetics and perfumes is not the only consideration that defines the growth dynamics of the entire industry. The growth
Biodegradable Cups Market - Consumer Outlook 2030 | Benders Paper Cup Company, W …
Global Biodegradable Cups Market: Overview The global biodegradable cups market is slated to expand at a stellar pace in the years to follow. It is worthwhile to note that the entire world is moving towards a greener and more sustainable future. This can be attributed to the efforts of environmentalists and young revolutionaries aiming to bring a change in the inclinations and mindsets of the masses. Therefore, the next decade is
Pre-press for Packaging Market - Worldwide Performance Report 2030 | Heidelberge …
Pre-press for Packaging Market: Overview The pre-press for packaging matter is anticipated to display notable growth over the forecast period from 2020 – 2030. The remarkable evolution of the printing sector is a key factor fuelling the pre-press for packaging market. Integration of computer-driven processes for printing and packaging solutions is creating opportunities in the pre-press for packaging market. Key parameters based on which the pre-press for packaging market is divided are
Artichokes Market Key Players, Latest Trends, Future Strategies And Growth Forec …
Global Artichokes Market: Overview Several botanists have studied the properties of edible plants over the years. This has led them to discover the health benefits of these plants, quite apparently for animals, and selectively for humans. Artichoke has also gained popularity due to increased spending on botanical and medical research. It is expected that the global artichokes market would expand at a sturdy pace in the years to follow. Research studies
More Releases for Diagnostics
Transplant Diagnostics Market
Transplant diagnostics is the examination of factors associated with recently performed transplant. This can be elaborated as safety testing, compatibility, testing, transplant feasibility testing, pre, peri, and post transplantation. This is done to check the tissue compatibility between the donor and patient in organ transplant. Major Players: The prominent players in the transplant diagnostics market are Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., QIAGEN, F. Hoffmann-La Roche Ltd., Illumina, Inc., Merck KGaA,
Demand for Rapid Diagnostics Tests Trending the Pneumonia Diagnostics Market
The World Health Organization estimates that pneumonia accounted for 16% of all deaths of children below the age of 5 years – more than 920,000 in 2015. The WHO states that the cost of pneumonia antibiotic treatment in the same year for child survival and newly born babies is roughly US$ 110 million annually. Therefore, there is a pressing need to analyse the pneumonia diagnostics market. In an upcoming report
Europe Transplant Diagnostics Market
The Europe Transplant Diagnostics Market Report is an upcoming report from Data Bridge Market Research. The new market report contains data for historic years 2015, the base year of calculation is 2017 and the forecast period is 2018 to 2025. Transplant diagnostics are the diagnostics tests performed while relocating organ in order to treat organ failure such as liver, pancreas, lungs, kidney, and heart. These tests are widely performed by skilled
Influenza Diagnostics Market
Influenza, commonly known as flu, is an infectious disease caused by the influenza virus. Three varieties of this virus affect people: type A, type B, and type C. Influenza spreads through infectious respiratory secretions caused by aerosol formation due to direct contact with an infected person. This virus can cause seasonal epidemics with high levels of morbidity and mortality. According to WHO, these epidemics were estimated to result in about
Global Influenza Diagnostics Market 2017 : BioMerieux, SA Scientific, Enigma Dia …
Influenza Diagnostics Market 2017 A market study based on the " Influenza Diagnostics Market " across the globe, recently added to the repository of Market Research, is titled ‘Global Influenza Diagnostics Market 2017’. The research report analyses the historical as well as present performance of the worldwide Influenza Diagnostics industry, and makes predictions on the future status of Influenza Diagnostics market on the basis of this analysis. Get Free Sample Copy of
Global Companion Diagnostics Market
The Global Companion Diagnostics (CDx) Market was valued at US$ 1,614.5 million in 2015 and is projected to expand at a CAGR of 12.0% during the forecast period (2016–2024), as highlighted in a new report published by Coherent Market Insights. Development of multiple biomarkers and targeted drug therapy is boosting research and development collaboration among the industry players. This is expected to improve the time to market for companion diagnostic (CDx) test